P673: DEPLETION AND RECOVERY OF NORMAL B-CELLS DURING AND AFTER TREATMENT WITH CHEMOIMMUNOTHERAPY, IBRUTINIB OR VENETOCLAX. (23rd June 2022) - Rawstron, A.; Webster, N.; Pitchford, A.; Dalal, S.; Bloor, A.; de Tute, R.; Hockaday, A.; Jackson, S.; Cairns, D.; Greatorex, N.; Allsup, D.; Munir, T.; et al.